Trial
NCT00040417
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
The Methodist Hospital Research Institute
Condition
Sickle Cell Anemia
Intervention
FLUDARABINE
Why stopped
unable to accrue patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-18